Clinical Trial: Semi-closed Loop Automated Insulin Therapy in the Pediatric Population Aged 2-6 Years with Type 1 Diabetes: Impact on Quality of Life and Glycemic Control

U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT06875167) titled 'Semi-closed Loop Automated Insulin Therapy in the Pediatric Population Aged 2-6 Years with Type 1 Diabetes: Impact on Quality of Life and Glycemic Control' on March 04.

Brief Summary: The incidence of type 1 diabetes is increasing, with an incidence of +4% per year in France today.

The treatment for type 1 diabetes is insulin therapy. In recent years, new systems have emerged, so-called "semi-closed loop" systems, also called automated insulin therapy, which have proven their superiority in terms of quality of life and glycemic balance in adults and children over 6 years old.

Since January 24, 2024, the HAS now recognizes the ind...